ALEXANDER GREFF: Open Payments
NPI 1578182564 · SHILOH, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 46 payments from 14 companies in 2025. Trend: 2023 $709 · 2024 $943 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $238 |
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| Novartis Pharmaceuticals Corporation | 1 | $106 |
| CSL Behring | 5 | $100 |
| GENZYME CORPORATION | 4 | $95 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Genentech USA, Inc. | 2 | $39 |
| Optinose US, Inc. | 2 | $37 |
Products named: CUVITRU, DUPIXENT, Rhapsido, TEZSPIRE, NEFFY, Andembry, Xolair, Hizentra.
Industry payments across IL — which companies pay providers there.
